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OBJECTIVES: We compared the risk of in-hospital mortality and the length of hospital stay between diabetic
and non-diabetic patients hospitalized for renal or perinephric abscess.
METHOD: The data analyzed in this study were retrieved from Taiwan’s National Health Insurance claims. The
risk of in-hospital mortality and the length of hospital stay were compared between 1,715 diabetic patients,
hospitalized because of renal or perinephric abscess in Taiwan between 1997 and 2007, and a random sample of
477 non-diabetes patients with renal or perinephric abscess.
RESULTS: The in-hospital mortality rates from renal or perinephric abscess for the diabetic patients and the non-
diabetic patients were not different, at 2.3% and 3.4%, respectively. However, diabetes was significantly
associated with a longer length of hospital stay among patients with renal abscess, by 3.38 days (95%
confidence interval [CI]: 1.59-5.17).
CONCLUSIONS: Diabetes does not increase the risk of in-hospital mortality from renal or perinephric abscess.
Nevertheless, appropriate management of patients with diabetes and concurrent renal or perinephric abscess is
essential to reduce the length of hospital stay.
KEYWORDS: Renal Abscess; Diabetes; Mortality; Length of Hospital Stay; Cohort Study.
Ko MC, Chiu AW, Liu CC, Liu CK, Woung LC, Yu LK, et al. Effect of diabetes on mortality and length of hospital stay in patients with renal or
perinephric abscess. Clinics. 2013;68(8):1109-1114.
Received for publication on March 18, 2013; First review completed on April 6, 2013; Accepted for publication on April 6, 2013
E-mail: lkyuhu@yahoo.com.tw
Tel.: 886 6 2748-316
& INTRODUCTION
Renal abscess (RA) and perinephric abscess are poten-
tially lethal complications of urinary tract infections (UTIs).
The insidious clinical course and variable symptoms and
signs at the time of clinical evaluation can cause difficulty in
the diagnosis of RA, thereby resulting in an increased case-
fatality rate in RA patients (1,2). Although progress in
imaging studies and the development of percutaneous
drainage techniques for retroperitoneal abscesses have
substantially decreased the case-fatality rate from RA (3,4),
in-hospital mortality rates have remained high, with rates
ranging from 5% to 15%, as reported in several recent
studies, including findings from Taiwan (5,6).
Diabetes is one of the most common endocrine diseases,
and its global prevalence for all age groups worldwide was
estimated to be 2.8% in 2000 and is predicted to reach 4.4%
in 2030. The total number of people with diabetes is
projected to rise from 171 million in 2000 to 366 million by
2030 (7). Diabetes is a serious illness with multiple
complications (8,9) and premature mortality, and it accounts
for at least 10% of the total health care expenditure in many
countries (10). Additionally, diabetes has frequently been
found to increase the risk of developing RA (11).
Patients with diabetes are at increased risk for infections
(12,13), particularly those originating in the urinary tract
(8). Diabetes can also cause several changes in the host
defense system, including defects in neutrophil function
(14), increased bacterial adherence to the uroepithelial cells
of diabetic patients (15) and decreased antibacterial activity
as a result of glycosuria (16). As a result, diabetic patients
tend to have a higher incidence and prevalence of
bacteriuria (17), and they are at a higher risk for developing
serious consequences, such as emphysematous cystitis,
pyelonephritis, renal papillary necrosis, and abscess
(18,19).
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With respect to the prognosis of diabetes-complicated
infections, such as bacteremia, sepsis, or liver abscess,
findings from previous studies have been inconsistent (20-
23). An earlier study (11) used a nationally representative
diabetic cohort, retrieved from the National Health
Insurance (NHI) database, to investigate the relative risk
of RA in diabetes, and found a significantly increased risk of
RA in diabetic patients. Using the same dataset, the present
study further explored whether RA patients with diabetes
have an increased risk of in-hospital mortality and whether
they experience an increased length of hospital stay (LOS)
compared to RA patients without diabetes.
& MATERIALS AND METHODS
The data analyzed in this study were obtained from our
previous study, which investigated the risk of admission for
RA in the diabetic population (11). The previous study,
based on Taiwan’s NHI claims, used a cohort study design
and followed more than a half million diabetic patients and
sex- and age-matched controls from 1997 to 2007.
Briefly, the diabetic cohort consisted of all individuals
(n = 500,867) who had an initial diabetes-related diagnosis
(ICD-9: 250 or A code 181) at any time in 1997 and who
received one or more additional diagnoses within the
subsequent 12 months. The control subjects (n = 500,365)
were matched to the diabetic cohort according to sex and
age and were identified from the registry of beneficiaries,
after the data of the diabetic group were excluded. Using
unique personal identification numbers, we linked the
ambulatory claims data of the study subjects to inpatient
claim records (1997-2007) to identify episodes of admission
for RA (ICD-9: 590.2). Over 11 years of follow-up, 1,715
diabetic patients were admitted for RA, whereas 477
controls were admitted with the same diagnosis, represent-
ing cumulative incidences of 0.34% and 0.10%, respectively.
After adjustment for confounders, diabetic patients had a
significantly increased hazard ratio (HR) (3.81) of admission
for RA (11).
Based on the above-mentioned previous report (11), the
present study employed a retrospective cohort design, in
which all 1,715 newly diagnosed RA patients with histories
of diabetes were recruited. The control group consisted of
477 newly diagnosed RA patients without a history of
diabetes in 1997. We linked the diabetic and non-diabetic
RA patients to the NHI inpatient claims between the time of
their first-time admissions for RA and the last day of 2007 to
examine whether they experienced in-hospital mortality.
The information on the LOS of the study subjects was based
on their first-time hospitalization for RA between 1997 and
2007.
To evaluate the effects of diabetes, sex, age, and treatment
modality on the risk of in-hospital mortality in RA patients,
we applied Cox’s multivariate proportional hazard regres-
sion analysis, with time to in-hospital mortality as the
dependent factor in the model. The index date of follow-up
was the RA date of first-time admission between 1997 and
2007. The date of the end of follow-up was the date of
discharge from the last hospitalization for individuals who
died or the date of termination of the NHI policy or the last
day of 2007 for individuals who were censored. The
treatment modality included antimicrobials only, percuta-
neous drainage (International Classification of Disease, 9th
version, Clinical Modification [ICD-9-CM], procedure
codes: 55.03 or 55.92), surgical drainage (ICD-9-CM proce-
dure codes: 55.01 or 55.02), and nephrectomy (ICD-9-CM
procedure codes: 55.51).
We also performedmultiple linear regressions to assess the
difference in LOS between RA patients with and without
diabetes. In addition to diabetic status, age, sex, and treatment
modality, we also included geographic area and urbanization
level in the multivariate model to account for possible
geographic and urbanization variations in cancer incidence
and mortality in Taiwan (24). All of the statistical analyses
were performed using SAS (version 9.2; SAS institute, Cary,
NC). P,0.05 was considered statistically significant. Access
to the NHI claims was reviewed and approved by the
National Health Research Institutes Review Committee.
& RESULTS
The RA patients with diabetes were younger than the
control patients (58.2¡12.4 vs. 64.5¡9.9 years old). Female
patients dominated the samples in both groups. The
distributions of geographic areas and urbanization levels
were similar in both groups. The treatment modalities used
were also similar in both groups (Table 1).
In-hospital mortality, in association with diabetes status,
sex, age, and treatment modality, is presented in Table 2.
The in-hospital mortality rates for the diabetic RA and non-
diabetic RA groups were 2.3% and 3.4%, respectively, which
represents a non-significantly reduced covariate-adjusted
HR of 0.91 (95% CI: 0.49-1.69, p= 0.759) for RA patients with
diabetes. Compared with the female RA patients, male RA
patients had a significantly higher hazard rate of in-hospital
mortality (adjusted HR=2.03). Additionally, older age
tended to be associated with a higher rate of in-hospital
mortality, and the highest adjusted HR (3.86) was noted in
the group .64 years old. With regard to treatment
modalities, 74.8% of the RA patients received antimicrobial
treatment alone, and the corresponding figures for percu-
taneous drainage, surgical drainage, and nephrectomy were
14.6%, 6.3%, and 4.3%, respectively. The in-hospital mortal-
ity rates for RA patients treated with antimicrobials alone,
percutaneous drainage, surgical drainage, and nephrectomy
ranged from 1.1% to 3.8%, but they were not significantly
different across treatment modality.
Table 3 compares the LOS between the two study groups.
The mean LOS for RA patients with and without diabetes
was 18.89 and 16.19 days, respectively. The covariate-
adjusted difference in LOS between the two groups (3.27
days) was statistically significant.
& DISCUSSION
Urinary tract infections are among the most common
bacterial infections. Renal abscess is a potentially lethal
complication of UTIs. Some previous studies have reported
the risk factors, clinical presentation, treatment modalities,
and outcomes of RA; however, almost all of them were
hospital-based (4,5,25,26). To our knowledge, our study is
the first to employ a population-based design to investigate
the risk of mortality from RA relative to diabetes.
Diabetes and other risk factors for in-hospital
mortality among patients hospitalized for RA
Recent hospital-based studies have reported in-hospital
mortality rates associated with RA ranging from 0% to 15%
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(4,5,25,26). In our study, the overall in-hospital mortality
rate was estimated at 2.6%, and diabetes did not increase the
risk of in-hospital mortality from RA. Patients with diabetes
often have abnormalities in both cell-mediated and humoral
immune responses (27). Diabetic patients may have an
increased risk of dying from an infectious disease, particu-
larly serious bacterial infections (28). However, evidence
obtained from previous studies has been inconsistent with
regard to the prognosis of complicated infections associated
with diabetes.
Table 1 - Characteristics of patients with renal or perinephric abscess according to diabetic status.
Variablesa RA
b patients without diabetes RA patients with diabetes
N % N %
Sex
Male 136 28.5 368 21.5
Female 341 71.5 1347 78.5
Age (years)
,45 10 2.1 232 13.5
45-54 71 14.9 379 22.1
55-64 139 29.1 542 31.6
.64 257 53.9 562 32.8
Mean (SD) 64.5 (9.9) 58.2 (12.4)
Geographic area
North 159 34.0 607 35.9
Central 118 25.2 417 24.6
South 166 35.5 570 33.7
East 25 5.3 99 5.8
Urbanization level
Metropolis 169 35.8 583 34.4
Satellite city 110 23.3 453 26.7
Rural area 193 40.9 658 38.9
Treatment modality
Antimicrobials only 349 73.2 1291 75.3
Percutaneous drainage 78 16.3 242 14.1
Surgical drainage 28 5.9 109 6.3
Nephrectomy 22 4.6 73 4.3
Total 477 100.0 1715 100.0
aInconsistency between total population and population summed from individual variables resulted from missing information.
bRA: renal or perinephric abscess.
Table 2 - Hazard ratio of in-hospital mortality relative to diabetes, age, sex, and treatment modality in patients with
renal or perinephric abscess (n = 2,192).
Variables
No. of patients
admitted
In-hospital
mortality Relative risk estimates
N % HRa 95% CIa p-value AHRa,b 95% CIb p-value
Diabetes
No 477 16 3.4 1.00 1.00
Yes 1,715 40 2.3 0.69 0.38-1.24 0.213 0.91 0.49-1.69 0.759
Sex
Male 504 21 4.2 2.05* 1.18-3.56 0.010 2.03* 1.15-3.59 0.015
Female 1,688 35 2.1 1.00 1.00
Age
,45 242 3 1.2 1.00 1.00
45-54 450 5 1.1 0.90 0.21-3.78 0.881 0.80 0.18-3.65 0.775
55-64 681 15 2.2 1.79 0.52-6.25 0.359 2.31 0.65-8.16 0.195
.64 819 33 4.0 3.34* 1.02-11.00 0.046 3.86* 1.15-12.98 0.029
Treatment modality
Antimicrobials only 1,640 39 2.4 1.00 1.00
Percutaneous drainage 320 12 3.8 1.60 0.83-3.09 0.162 1.30 0.63-2.66 0.478
Surgical drainage 137 4 2.9 1.24 0.44-3.51 0.692 1.51 0.52-4.39 0.448
Nephrectomy 95 1 1.1 0.44 0.06-3.21 0.416 0.45 0.06-3.40 0.442
Total 2192 56 2.6
aHR=hazard ratio; CI = confidence interval; AHR=adjusted hazard ratio.
bEstimated from Cox’s multivariate proportional hazard model, with diabetes, age, sex, treatment modality, geographic area, and urbanization level
simultaneously included in the model.
*p,0.05.
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One population-based epidemiological study suggested
that diabetes is an important prognostic factor for severe
Gram-negative infections, including bacteremia, and the
authors concluded that among patients with bacteremia,
diabetes was also associated with a poorer prognosis. We
speculated that latent diabetic organ disease would render
patients with diabetes particularly vulnerable to multiorgan
failure associated with Gram-negative sepsis. Protracted
multiorgan failure promoted by diabetic organ disease
could play a role in the higher mortality among diabetic
patients (20). Another study on the association of diabetes
with liver abscess-related mortality also reported a higher
30-day post-discharge mortality rate in patients with
diabetes. We argue that the harmful effects of hyperglyce-
mia, general diabetic angiopathy, and decreased immunity
may be possible pathophysiological mechanisms (21).
In contrast, Foo et al. (22) demonstrated that in patients
with pyogenic liver abscesses, diabetes was not a predictor
of case fatality. We argue that because the growth of
pyogenic liver abscess occurred mostly in immunocompro-
mised patients, other etiologies of immunodeficiency should
be more prevalent in the non-diabetic group (22). Stegenga
et al. (23) also reported that the outcome of severe sepsis
was not influenced by the presence of diabetes. We found
no strong influence of diabetes on the host response to
severe sepsis, possibly because sepsis and diabetes both
induced a pro-coagulant state and both interfered with an
adequate inflammatory reaction. The modest effect of pre-
existing diabetes on the host response to sepsis may result
from disturbances of the coagulation system and the
inflammatory responses caused by severe sepsis being
stronger and more important for outcomes than the
relatively smaller derangements attributable to coexistent
diabetes (23). Along with our earlier report (11), the present
data indicate that diabetes is associated with a significantly
elevated risk of RA, but diabetes does not increase the risk
of in-hospital mortality from RA.
In our study, 74.8% of patients with RA received
antimicrobial treatment alone. We found no differences in
the risk of in-hospital mortality among the different
treatment modalities. Previous studies have reported that
renal abscess can be treated with antimicrobials alone,
whereas drainage procedures have always been necessary
for perinephric abscess or mixed abscess (5,25,26). Some
other studies have also reported that small perinephric
abscesses with a diameter ,3 cm in clinically stable patients
could be treated successfully with antimicrobials alone
(4,29). Compared with previous studies, most of which were
conducted in tertiary teaching hospitals or in referral
centers, our study found a higher proportion of patients
receiving antimicrobials alone as a treatment modality for
RA. Patients admitted to tertiary teaching hospitals or
referral centers tend to be more severely ill, so drainage
procedures are expected to be performed more frequently in
such patients. However, our study found no association of
treatment modality with the risk of in-hospital mortality,
which suggests that the clinical management delivered to
RA patients in Taiwan is appropriate.
Although there was no significant association of diabetes
or treatment modality with in-hospital mortality from RA,
this study did find that male patients and older (.64 years)
patients had a significantly higher risk of in-hospital
mortality. Yen et al. (25) reported an in-hospital mortality
rate of 14% from RA and found that older age, elevated
blood urea nitrogen, and lethargy were all significant risk
factors for mortality. Lin et al. reported an in-hospital
mortality rate of 8% and noted that age .64 years,
thrombocytopenia, and abscess without drainage were risk
factors for poor outcome (nephrectomy or mortality); they
also found that the patients in the delayed diagnosis group
were older than the patients in the early diagnosis group.
Delayed diagnosis and co-morbidity in the older patients
were found to be responsible for the increased risk of case-
fatality from RA (6).
It is generally agreed that men with UTIs require
thorough urological evaluations to identify predisposing
structural or functional abnormalities, which are common in
men with UTIs (30,31). Although the pathogens in men with
community-acquired febrile UTIs were similar to those in
women, with a predominance of Escherichia coli (E. coli), and
the distributions of E. coli serotypes were similar between
men and women, the distributions of virulence properties
are quite different between men and women (32). Studies
have found a higher proportion of hemolytic strains but a
lower frequency of P-fimbriated and aerobactin-producing
strains in women, which suggests different host-parasite
relationships in the male and female urinary tracts (32).
Associated urinary tract abnormalities and different host-
parasite relationships may be responsible for the increased
mortality risk from RA in male patients.
Diabetes-associated length of hospital stay in RA
patients
Notably, we found that diabetes increased the LOS by
3.27 days in patients with RA. As the most common
endocrine disease, diabetes was also incorporated into the
Charlson Comorbidity Index (CCI), which takes into
account 19 predetermined clinical conditions and is a strong
predictor of various clinical adverse outcomes (33). Yang
et al. (34) reported that a higher grade of co-morbidity was
Table 3 - Comparison of length of hospital stay between renal or perinephric abscess patients according to their diabetic
status (N=2,192).
Variables
No. of patients
admitted LOS
a Difference in mean LOS
Mean SDa Crude aˆa 95% CIa p-value Adjusted aˆa,b 95% CI p-value
Diabetes
No (reference) 461 16.19 15.62
Yes 1675 18.89 16.62 2.70* 1.01-4.40 0.002 3.27* 1.55-5.00 ,0.0001
aLOS= length of hospital stay; SD= standard deviation; aˆ = regression coefficient,CI = confidence interval.
bEstimated from multivariate linear regression model with adjustment for age, sex, treatment modality, geographic area, and urbanization level.
*p,0.05.
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significantly associated with sepsis and therefore with a
longer LOS. The longer LOS may have reflected clinical
difficulty in caring for RA patients with diabetes.
Strengths and limitations
Our study had several methodological strengths. First, we
used NHI data, which reduced selection or recall bias, and
there was little likelihood of non-response and loss to
follow-up among the cohort members. Second, the large
number of study subjects also made it possible for us to
conduct analyses of certain variables of interest, including
age, sex, and treatment modality. Third, the advantage of
using insurance claims data in clinical research is easy
access to longitudinal records for a large sample of
geographically dispersed patients, which greatly increases
the representativeness of the study sample. Fourth,
although we identified RA patients from inpatient claims,
most cases of RA in Taiwan are diagnosed by imaging
studies, including ultrasound, computed tomography, or
magnetic resonance imaging; percutaneous aspiration; and
surgical exploration (6,25), which supports the validity of
the RA diagnoses.
Several limitations of our study should be noted. First,
exclusive reliance on claim data may have resulted in
potential misclassification bias in our study. The accuracy of
a single diabetes diagnosis in the NHI claims data in 2000
was reported to be 74.6% (35). However, we used at least
two diabetes-related diagnoses with the first and last visits
more than 30 days apart, which would have largely reduced
the likelihood of disease misclassification. Second, we could
not differentiate between type 1 and type 2 diabetes among
the diabetic population included in our study. In Taiwan,
type 1 diabetes constitutes only 1.8% of all types of diabetes
(36), and the ratio of newly diagnosed type 2 to type 1
diabetes among school children aged 6 to 18 years old is
approximately six to one (37). Therefore, the majority of our
young diabetic patients tended to be type 2 diabetes
patients. Third, the study subjects recruited for the current
analysis were originally selected for the investigation of
diabetes in predicting RA risk; therefore, the RA patients
analyzed may not be representative of the entire RA
population diagnosed during the study period. To address
this issue, we compared characteristics between our study
RA patients and other RA patients hospitalized during the
study period. It should be noted that our study RA patients
were older (59.6 vs. 45.4 years). This difference is attribu-
table to our study RA patients having been selected from the
diabetic population and the age- and sex-matched non-
diabetic beneficiaries being older than the general popula-
tion in general. The in-hospital mortality and length of
hospital stay estimated from our study RA patients were
therefore likely to be over-estimated. Thus, the findings of
our analysis should be generalized with caution. Fourth,
Taiwan’s NHI claims data do not include laboratory test
results, which prevented us from further evaluating the
potential effects of bacterial virulence on the risk of
mortality in RA patients. One study in Taiwan reported
that, among the 111 pathogens isolated from abscesses or
from urine samples from RA patients, E. coli was the most
common organism (36%), followed by Klebsiella pneumoniae
(20%). Previous studies have also found that the pathogens
of RA are independent of diabetic status, and the RA
pathogens did not influence the risk of mortality (25).
Finally, as is the case with most observational studies
using linked administrative data, confounding may be a
source of concern. We could not determine a comprehensive
list of potential risk factors for mortality and LOS in the
study subjects, which may also have confounded the study
results.
In conclusion, our data show that RA patients with
diabetes in Taiwan do not have an elevated risk of in-
hospital mortality. However, among the patients hospita-
lized for RA, male patients and older (.64 years old)
patients were at significantly higher risks for in-hospital
mortality. Additionally, diabetes may increase the average
LOS in RA patients. Given the longer LOS noted in RA
patients with diabetes, appropriate clinical management of
these patients during their hospital stay is essential to
reduce the LOS.
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